Global mRNA Vaccines Market Size – Forecasts to 2028
January 10, 2023 09:15 ET
|
Global Market Estimates
Brooklyn, New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global mRNA Vaccines Market is projected to grow at a CAGR...
Vaccines & Therapeutics Market Size in 2023 (New Report): Manufacturers Data, Opportunity, Import Export Scenario, Application, Showing Impressive Growth | No. of pages: 82
January 10, 2023 05:16 ET
|
Proficient Market Insights
pune, Jan. 10, 2023 (GLOBE NEWSWIRE) -- "Vaccines & Therapeutics Market" research report focus on overall information that can help to take decisions on current market situation. Vaccines &...
Vaxcyte’s VAX-24 Granted FDA Breakthrough Therapy Designation for the Prevention of Invasive Pneumococcal Disease in Adults
January 05, 2023 08:30 ET
|
Vaxcyte, Inc.
-- Breakthrough Therapy Designation for 24-Valent Investigational Pneumococcal Conjugate Vaccine Candidate Based on Positive Topline Proof-of-Concept Data Results in Adults Aged 18-64 That Suggest...
Global Messenger RNA (mRNA) Vaccines & Therapeutics Market Research Report 2022 Featuring Pfizer, GSK, Daiichi Sankyo, Intellia Therapeutics, Moderna, CureVac, Arcturus Therapeutics, & BioNTech
January 05, 2023 04:03 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Messenger RNA (mRNA) Vaccines & Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity...
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
The Worldwide Human Rabies Vaccines Industry is Expected to Reach $932.4 Million by 2027 at a 6.23% CAGR
December 28, 2022 06:33 ET
|
Research and Markets
Dublin, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Human Rabies Vaccines Market (2022-2027) by Cell Line Type, Route of Administration, Applications, Distribution Channel, and Geography, with...
RNA Therapeutics market is projected to grow at a CAGR of 18.68% by 2032: Visiongain Reports Ltd
December 26, 2022 06:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: RNA Therapeutics Market, (COVID-19 Impact Analysis):- Market Segment by Type {RNA Antisense Technologies, RNA Interference (RNAi) Technologies}, Market Segment...
Global BCG Tuberculosis Vaccine (Immune, Therapy) Markets, Analysis & Forecasts, 2017-2021 & 2022-2030
December 22, 2022 05:48 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Global BCG Tuberculosis Vaccine Market, by Product Type, by Application, Estimation & Forecast, 2017- 2030" report has been added to ...
BiondVax Announces Closing of $8 Million Underwritten Public Offering
December 20, 2022 12:42 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Dec. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV)(“Company”), a biotechnology company, which focuses on developing, manufacturing, and...
Bioreactors Market to hit USD 28 billion by 2032, says Global Market Insights Inc.
December 14, 2022 02:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The bioreactors market value is anticipated to garner over USD 28 billion by 2032, according to the recent research report by Global Market...